ARTICLE | Company News
DEKK-TEC Inc., Ziopharm Inc. deal
November 15, 2004 8:00 AM UTC
DEKK-TEC granted Ziopharm an exclusive worldwide license to a metabolite of ifosfamide to treat cancer. An ongoing Phase I trial is expected to be completed in the first quarter of 2005. Ziopharm plan...